Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.

Schilling RJ.

Heart. 2010 Mar;96(5):333-8. doi: 10.1136/hrt.2008.155812. Epub 2009 Nov 11. Review.

PMID:
19910286
[PubMed - indexed for MEDLINE]
2.

Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.

Kirchhof P, Fetsch T, Hanrath P, Meinertz T, Steinbeck G, Lehmacher W, Breithardt G.

Am Heart J. 2005 Nov;150(5):899.

PMID:
16290956
[PubMed - indexed for MEDLINE]
3.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
[PubMed - indexed for MEDLINE]
4.

Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.

Nergärdh A, Nordlander R, Frick M.

Clin Cardiol. 2006 Feb;29(2):56-60.

PMID:
16506639
[PubMed - indexed for MEDLINE]
5.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
[PubMed - indexed for MEDLINE]
6.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
[PubMed - indexed for MEDLINE]
7.

Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Boriani G, Diemberger I, Biffi M, Martignani C, Branzi A.

Drugs. 2004;64(24):2741-62. Review.

PMID:
15563247
[PubMed - indexed for MEDLINE]
8.
9.

Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?

Tieleman RG, Van Gelder IC, Bosker HA, Kingma T, Wilde AA, Kirchhof CJ, Bennekers JH, Bracke FA, Veeger NJ, Haaksma J, Allessie MA, Crijns HJ.

Heart Rhythm. 2005 Mar;2(3):223-30.

PMID:
15851308
[PubMed - indexed for MEDLINE]
10.

Rate versus rhythm control in atrial fibrillation.

Wijffels MC, Crijns HJ.

Cardiol Clin. 2004 Feb;22(1):63-9. Review.

PMID:
14994848
[PubMed - indexed for MEDLINE]
11.

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.

Singh SN, Tang XC, Reda D, Singh BN.

Heart Rhythm. 2009 Feb;6(2):152-5. doi: 10.1016/j.hrthm.2008.10.036. Epub 2008 Oct 29.

PMID:
19187902
[PubMed - indexed for MEDLINE]
12.

Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion.

Opolski G, Stanisławska J, Górecki A, Swiecicka G, Torbicki A, Kraska T.

Clin Cardiol. 1997 Apr;20(4):337-40.

PMID:
9098591
[PubMed - indexed for MEDLINE]
13.

Pharmacologic management of atrial fibrillation: established and emerging options.

Kalus JS.

J Manag Care Pharm. 2009 Aug;15(6 Suppl B):S10-8. Review.

PMID:
19678722
[PubMed - indexed for MEDLINE]
Free Article
14.

Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.

Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.

Heart. 2002 May;87(5):443-8.

PMID:
11997417
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.

Rajagopalan B, Curtis AB.

Postgrad Med. 2012 Nov;124(6):26-35. doi: 10.3810/pgm.2012.11.2610. Review.

PMID:
23322136
[PubMed - indexed for MEDLINE]
16.

Do we need pharmacological therapy for atrial fibrillation in the ablation era?

Lévy S.

J Interv Card Electrophysiol. 2006 Dec;17(3):189-94. Epub 2007 Mar 6. Review.

PMID:
17340189
[PubMed - indexed for MEDLINE]
17.

VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).

De Simone A, De Pasquale M, De Matteis C, Canciello M, Manzo M, Sabino L, Alfano F, Di Mauro M, Campana A, De Fabrizio G, Vitale DF, Turco P, Stabile G.

Eur Heart J. 2003 Aug;24(15):1425-9.

PMID:
12909071
[PubMed - indexed for MEDLINE]
Free Article
18.

Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.

Opolski G, Torbicki A, Kosior D, Szulc M, Zawadzka M, Pierścińska M, Kołodziej P, Stopiński M, Wozakowska-Kapłon B, Achremczyk P, Rabczenko D.

Kardiol Pol. 2003 Jul;59(7):1-16; discussion 15-16.

PMID:
14560344
[PubMed - indexed for MEDLINE]
19.

Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.

Crijns HJ.

Drugs. 2005;65(12):1651-67. Review.

PMID:
16060699
[PubMed - indexed for MEDLINE]
20.

Current management of symptomatic atrial fibrillation.

Haghi D, Schumacher B.

Am J Cardiovasc Drugs. 2001;1(2):127-39. Review.

PMID:
14728042
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk